Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Unii-6jon30sldt
2. 6jon30sldt
3. Isis-304801 Sodium
4. Volanesorsen Sodium [usan]
5. Isis-304801 Sodium Salt
6. 1573402-50-2
| Molecular Weight | 7583 g/mol |
|---|---|
| Molecular Formula | C230H301N63Na19O125P19S19 |
| Hydrogen Bond Donor Count | 25 |
| Hydrogen Bond Acceptor Count | 162 |
| Rotatable Bond Count | 156 |
| Exact Mass | 7579.6964806 g/mol |
| Monoisotopic Mass | 7577.6897709 g/mol |
| Topological Polar Surface Area | 2970 Ų |
| Heavy Atom Count | 475 |
| Formal Charge | 0 |
| Complexity | 20400 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 70 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 20 |
Waylivra is indicated as an adjunct to diet in adult patients with genetically confirmed familial chylomicronemia syndrome (FCS) and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate.
C10AX18
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
ABOUT THIS PAGE
A Volanesorsen Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Volanesorsen Sodium, including repackagers and relabelers. The FDA regulates Volanesorsen Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Volanesorsen Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Volanesorsen Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Volanesorsen Sodium supplier is an individual or a company that provides Volanesorsen Sodium active pharmaceutical ingredient (API) or Volanesorsen Sodium finished formulations upon request. The Volanesorsen Sodium suppliers may include Volanesorsen Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Volanesorsen Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Volanesorsen Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Volanesorsen Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Volanesorsen Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Volanesorsen Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Volanesorsen Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Volanesorsen Sodium suppliers with NDC on PharmaCompass.
Volanesorsen Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Volanesorsen Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Volanesorsen Sodium GMP manufacturer or Volanesorsen Sodium GMP API supplier for your needs.
A Volanesorsen Sodium CoA (Certificate of Analysis) is a formal document that attests to Volanesorsen Sodium's compliance with Volanesorsen Sodium specifications and serves as a tool for batch-level quality control.
Volanesorsen Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Volanesorsen Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Volanesorsen Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Volanesorsen Sodium EP), Volanesorsen Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Volanesorsen Sodium USP).
LOOKING FOR A SUPPLIER?
